CHEMINFORMATICS

 

 

Here we look at how big data and AI are driving our development of new drug discovery platforms.

THIS YEAR’S WORLD LEADING CHEMINFORMATICS SPEAKERS

 

 

 

Cheminformatics, Tuesday 2 November 2021

08:40

Opening Remarks

Trevor Howe
09:00

Looking at the bigger picture: How do we make sure that we have the full picture with big data experiments

Joachim Reischl
09:20

Deep Medicine – towards the next generation of software-based precision medicine diagnostics

  • Evolution of precision medicine
  • AI in predicting clinical outcome
  • Software as Medical Device as Companion Diagnostic
Panel discussion
09:40

Essential Tools for Accelerating Pipeline Productivity & Success

What tools are in your toolkit? Join this leading biopharma panel discussion to find out how to give your AI-based drug discovery and development program a competitive edge and increase program success.
10:40

Networking Break

13:20

Networking Lunch Break

16:20

Networking Break

18:00

Neri & Sons Band & Networking Drinks Reception

last published: 27/Jul/21 14:25

Cheminformatics, Wednesday 3 November 2021

Steffen Roellinger
09:00

Decentralised Clinical Trials

  • Discussing the adoption of decentralised clinical trials at Bayer
  • New digital addoption
  • The Bayer trials transformaiton over COVID-19
Andrew Kasarskis
09:00

Digital transformation over COVID-19 – Challenges for the future and perpetuating the efforts

  • COVID-19 lead to digital innovation by necessity, including telehealth, new apps and digital technologies, and data fusion and sharing advances.
  • Large opportunities exist to do much better with learning from data, however.This requires the following operational and cultural change:
-Proactive collection and use of coherent data sets as a baseline for public health and the infrastructure development to support that work.-Recommitment to evidence-based medicine and timely, rigorous assessment of clinical utility through ongoing clinical research with well-powered studies of strong statistical design coupled to careful monitoring of large observational data.
Said Ismail
09:20

Qatar Genome; Big data from an underrepresented region

  • Overview of the Qatar Genome Project (QGP)
  • Contributions to Middle East Genomics
  • QGP role COVID-19 research
  • Strategy for precision medicine implementation
09:20

SevenBridges

Panel discussion
09:40

BC Platforms - Keynote Panel

Paul Agapow
09:40

How to be right: effective use of clinical models and machine learning in the clinic

    There is an increasing demand for a sophisticated model to predict patient outcomes and suggest treatmentsUnfortunately, most proposed clinical models are not fit for purpose, being biased, unvalidated, or irrelevantHere we suggest best practices for the development and deployment of complex ML algorithms, resulting in more successful and effective models
10:20

Networking Break + Speed Networking

13:00

Networking Lunch Break

Cheminformatics
14:40

Discngine

Nils Weskamp
Cheminformatics
15:00

GPS for Chemical Space - Digital Assistants to Support Molecule Design

  • eDesign: our computational platform for molecule design and optimization
  • How to combine data, algorithms and user experience to impact compound design
  • Agile and interdisciplinary teamwork as a success factor for the development and acceptance of digital tools
Cheminformatics
15:20

CAS

Samuel Egieyeh
Cheminformatics
15:40

Application of Molecular modelling, Cheminformatics and Data science Techniques in the Discovery of Potential Small Molecules and Peptides against SARS CoV-2 Wild Type and Mutants

  • Molecular modelling and dynamics aid the design of PLGA-Chitosan co-polymer nanoparticles for the stimulation of macrophages against Mycobacterium Tuberculosis
16:00

Networking Break

Andrew Hercules
Cheminformatics
17:00

Workshop - Open Targets Platform: pre-competitive insights for systematic drug target identification and prioritisation

In this 40-minute interactive workshop, you will learn how the Open Targets Platform can help you answer your research questions about drug target identification and prioritisation. For example:
  1. What drug targets are associated with psoriasis that have Open Targets Genetics Portal evidence, are expressed in immune system pathways and are predicted tractable for antibody compounds with high confidence?
  2. What diseases and phenotypes are associated with EIF4G1 that have Project Score evidence from Behan, et al 2019 (PMID: 30971826)?
  3. What are the black box warnings and adverse events for metformin?
You will also learn how to access all of our open data across different data touchpoints, including the web interface, API playground, and Google BigQuery.No advance preparation is necessary. And no previous technical or programming skills are needed as we support multiple ways to access our data.But we do encourage you to bring your laptop as we will provide interactive walkthroughs and sample scripts and API queries that you can run directly in your browser.To learn more about the Platform before the workshop, visit the Platform (https://platform.opentargets.org/), read our documentation (https://platform-docs.opentargets.org/), and check out our latest publication (https://doi.org/10.1093/nar/gkaa840).
18:00

Drinks Reception

last published: 27/Jul/21 14:25

Cheminformatics, Thursday 4 November 2021

Scott Chandler
09:00

Genetic Drivers of Response to Immunotherapy: Going Beyond the Tumor

09:20

GenomeSys

Thomas Hach
10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
last published: 27/Jul/21 14:25

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034